These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25300276)

  • 21. [Conflicts of interest: an introduction to a new focus point].
    Rzany B
    J Dtsch Dermatol Ges; 2011 Apr; 9(4):267-8. PubMed ID: 21439009
    [No Abstract]   [Full Text] [Related]  

  • 22. [Emerging concepts in clinical practice guidelines].
    Preiss JC; Timmer A; Zeitz M; Hoffmann JC
    Z Gastroenterol; 2007 Oct; 45(10):1075-81. PubMed ID: 17924306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rating the strength of scientific evidence: relevance for quality improvement programs.
    Lohr KN
    Int J Qual Health Care; 2004 Feb; 16(1):9-18. PubMed ID: 15020556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACCP evidence-based guideline development: a successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations.
    Baumann MH; Lewis SZ; Gutterman D;
    Chest; 2007 Sep; 132(3):1015-24. PubMed ID: 17540835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
    Alpert JS
    Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678
    [No Abstract]   [Full Text] [Related]  

  • 26. [The prescriber and the pedagogue].
    Chabot JM
    Rev Prat; 2001 Jan; 51(2):185-6. PubMed ID: 11252945
    [No Abstract]   [Full Text] [Related]  

  • 27. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are the Institute of Medicine's trustworthiness guidelines trustworthy?
    Young BK; Greenberg PB
    R I Med J (2013); 2013 Jul; 96(8):13-4. PubMed ID: 23923118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guided clinical practice guidelines: how to blunt the weapon of evidence].
    Maestri E; Formoso G
    Assist Inferm Ric; 2015; 34(1):35-43. PubMed ID: 25837334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Financial disclosures in clinical practice guidelines.
    Kahn JM; Rubenfeld GD
    Crit Care Med; 2010 Aug; 38(8):1755-6; discussion 1756-7. PubMed ID: 20647810
    [No Abstract]   [Full Text] [Related]  

  • 33. Diabetologist's perspective on practice of evidence based diabetes management in India.
    Hasan H; Zodpey S; Saraf A
    Diabetes Res Clin Pract; 2012 Feb; 95(2):189-93. PubMed ID: 22001282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Burgers JS; Anzueto A; Black PN; Cruz AA; Fervers B; Graham ID; Metersky M; Woodhead M; Yawn BP;
    Proc Am Thorac Soc; 2012 Dec; 9(5):304-10. PubMed ID: 23256175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Guideline development: Going from evidence to recommendations. Challenges and opportunities--a methodologist's view].
    Mahlknecht P; Glechner A; Gartlehner G
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):319-29. PubMed ID: 26354132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention to sex-related factors in the development of clinical practice guidelines.
    Keuken DG; Haafkens JA; Moerman CJ; Klazinga NS; ter Riet G
    J Womens Health (Larchmt); 2007; 16(1):82-92. PubMed ID: 17324099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Guyatt G; Akl EA; Oxman A; Wilson K; Puhan MA; Wilt T; Gutterman D; Woodhead M; Antman EM; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):256-61. PubMed ID: 23256168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing conflict of interest: the academy's preferred practice patterns and ophthalmic technology assessments.
    Parke DW; Coleman AL; Lum F
    Ophthalmology; 2011 Aug; 118(8):1493-4. PubMed ID: 21813089
    [No Abstract]   [Full Text] [Related]  

  • 39. [A series on factual medicine (evidence-based medicine): for what objectives?].
    Perrier A; Similowski T
    Rev Mal Respir; 2002 Sep; 19(4):395-8. PubMed ID: 12417851
    [No Abstract]   [Full Text] [Related]  

  • 40. Using evidence in pain practice: Part I: Assessing quality of systematic reviews and clinical practice guidelines.
    Chou R
    Pain Med; 2008; 9(5):518-30. PubMed ID: 18346062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.